Your browser doesn't support javascript.
loading
Phase 2a Clinical Trial of Mitochondrial Protection (Elamipretide) During Stent Revascularization in Patients With Atherosclerotic Renal Artery Stenosis.
Saad, Ahmed; Herrmann, Sandra M S; Eirin, Alfonso; Ferguson, Christopher M; Glockner, James F; Bjarnason, Haraldur; McKusick, Michael A; Misra, Sanjay; Lerman, Lilach O; Textor, Stephen C.
Affiliation
  • Saad A; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Herrmann SMS; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Eirin A; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Ferguson CM; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Glockner JF; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Bjarnason H; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • McKusick MA; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Misra S; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Lerman LO; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN.
  • Textor SC; From the Division of Nephrology and Hypertension (A.S., S.M.S.H., A.E., C.M.F., L.O.L., S.C.T.) and Department of Radiology (J.F.G., H.B., M.A.M., S.M.), Mayo Clinic, Rochester, MN. stextor@mayo.edu.
Circ Cardiovasc Interv ; 10(9)2017 Sep.
Article in En | MEDLINE | ID: mdl-28916603

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Renal Artery Obstruction / Stents / Angioplasty, Balloon / Oxidative Stress / Atherosclerosis / Kidney / Mitochondria / Antioxidants Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2017 Document type: Article Affiliation country: Mongolia Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Oligopeptides / Renal Artery Obstruction / Stents / Angioplasty, Balloon / Oxidative Stress / Atherosclerosis / Kidney / Mitochondria / Antioxidants Type of study: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Language: En Journal: Circ Cardiovasc Interv Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2017 Document type: Article Affiliation country: Mongolia Country of publication: United States